Markerii Imunohistochimici P53, Bcl 2, Ki 67, Egfr Si Pten In Cancerul Colorectal

CUPRINS

CUPRINS

IMPORTANȚA STUDIULUI

I. STADIUL ACTUAL AL CUNOAȘTERII ÎN CANCERUL COLORECTAL

Capitolul 1. Date de anatomie și structură histologică a colonului și rectului

Capitolul 2. Cancerul colorectal – anatomie patologică. Markeri imunohistochimici

Capitolul 3. Diagnosticul și complicațiile cancerului colorectal

Capitolul 4. Tratamentul și prognosticul cancerului colorectal

II. CONTRIBUȚII PERSONALE ÎN STUDIUL CANCERULUI COLORECTAL

Capitolul 5. Contribuții personale în studiul rezultatelor tratamentului chirurgical în cancerul colorectal

5.1 Importanța studiului chirurgical

5.2 Material și metodă

5.3 Contribuții personale

5.4 Discuții

5.5 Concluzii

Bibliografie

Capitolul 6. Contribuții personale în studiul anatomopatologic al cancerului colorectal

6.1 Motivația și obiectivele studiului

6.2 Material și metodă

6.3 Contribuții personale

6.4 Discuții

6.5 Concluzii

Bibliografie

Capitolul 7. Contribuții personale în studiul markerilor imunohistochimici p53, bcl-2, Ki67, PTEN și EGFR în cancerul colorectal

7.1 Motivația și importanța studiului markerilor imunohistochimici

7.2 Material și metodă

7.3 Contribuții personale

7.4 Discuții

7.5 Concluzii

Bibliografie

CONCLUZII FINALE

BIBLIOGRAFIE

BIBLIOGRAFIE

ABDALLA E, VAUTHEY JN, ELLIS L, ELLIS V, POLLOCK R, BROGLIO K, HESS K, CURLEY S – Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection / ablation for colorectal liver metastases. Ann Surg, 2004, 239:818–827

ALEXANDER D, JHALA N, CHATLA C, STEINHAUER J, FUNKHOUSER E, COFFEY C, GRIZZLE W, MANNE U – High-grade tumor differentiation is an indicator of poor prognosis in African Americans with colonic adenocarcinomas. Cancer, 2005, 103(10): 2163–2170.

ANDREONI B, CHIAPPA A, BERTANI E, BELLOMI M, ORECCHIA R, ZAMPINO MG, FAZIO N, VENTURINO M, ORSI F, SONZOGNI A, PACE U, MONFARDINI L – Surgical outcomes for colon and rectal cancer over a decade: results from a consecutive monocentric experience in 902 unselected patients. World J Surg Oncol, 2007, 5:73.

ANGELESCU N, POPA E, BURCOȘ T, JITEA N, ANGELESCU M – Cancerul rectal – între rezecție și amputație. Decalogul chirurgului. Chirurgia, 2003, 98(4):301-306.

ARDELEANU C, COMĂNESCU V, ZAHARIA B – Imunohistochimie. Editura SITECH, Craiova, 1999, 116-132.

AȘCHIE MARIANA, BEJAN L, DEACU M, BOSOTEANU M (sub red.) – Clinical Morphopathology, vol. I și II. Ed. Muntenia&Leda, Constanța, 2001a.

AȘCHIE MARIANA (ed.) – Limfoamele maligne non-hodgkiniene gastrointestinale – entități anatomo-clinice și morfologice. Ed. Muntenia & Leda, Constanța, 2001b.

ASCHIE MARIANA, CRACIUN ANCA, MITROI ANCA, CHISOI ANCA, POINAREANU I, ILIESIU ANDREEA – Pathologic and immunohistochemical features of digestive neuroendocrine tumors. Ars Med Tomitana, 2010, XVI(1).

ATZIL S, ARAD M, GLASNER A, ABIRI N, AVRAHAM R, GREENFELD K, ROSENNE E, BEILIN B, BEN-ELIYAHU S – Blood transfusion promotes cancer progression: a critical role for aged erythrocytes. Anesthesiology, 2008, 109(6): 989–997.

BAKX R, VISSER O, JOSSO J, MEIJER S, SLORS F, van LANSCHOT J – Management of recurrent rectal cancer: a population based study in greater Amsterdam. World J Gastroenterol, 2008, 14(39):6018-6023.

BALRAJ P, RUHANA S – PTEN mutation studies in malaysian colorectal cancer patients. As Pac J Mol Biol Biotechnol, 2007, 15(1):23-25.

BĂRBULESCU M – Factorii prognostici ai cancerului colorectal. Jurnalul de Chirurgie, Iași, 2007, 3(2):117-129.

BELL W, YOUNG ES, BILLINGS P, GRIZZLE W – The efficient operation of the surgical pathology gross room. Biotech Histochem, 2008, 83(2):71–82.

BENZONI E, INTERSIMONE D, TERROSU G, BRESADOLA V, COJUTTI A, CERATO F, AVELLINI C – Prognostic value of tumour regression grading and depth of neoplastic infiltration within the perirectal fat after combined neoadjuvant chemo-radiotherapy and surgery for rectal cancer. J Clin Pathol, 2006, 59:505–512.

BERNICK P, KLIMSTRA D, SHIA J, MINSKY B, SALTZ L, SHI W, THALER H, GUILLEM J, PATY P, COHEN A, WONG W – Neuroendocrine carcinomas of the colon and rectum. Dis Colon Rectum, 2004, 47:163–169.

BLESSING K, SANDERS D, GRANT J – Comparison of immunohistochemical staining of the novel antibody melan-A with S100 protein and HMB-45 in malignant melanoma and melanoma variants. Histopathology, 1998, 32(2):139-146.

BOENISCH T (ed.) – Immunochemical staining methods, 3rd edition. Ed Dako Corporation, Carpinteria, California, 2001.

BOKEY E, CHAPUIS P, FUNG C, HUGHES W, KOOREY S, BREWER D, NEWLAND R – Postoperative morbidity and mortality following resection of the colon and rectum for cancer. Dis Colon Rectum, 1995, 38:480-487.

BOKEY E, CHAPUIS P, DENT O, MANDER B, BISSETT I, NEWLAND R – Surgical technique and survival in patients having a curative resection for colon cancer. Dis Colon Rectum, 2003, 46:860–866.

BRESALIER R – Malignant & Premalignant Lesion of the Colon. In: “Current Diagnosis & Treatment in Gastroenterology”, 2nd Edition, (Friedman S, McQuaid K, Grendell J eds). McGraw-Hill/Appleton & Lange, 2002, 251-264.

BULIGESCU L. (sub red.) – Cancerul colo-rectal. În „Tratat de Hepato-gastro-enterologie“, vol. I. Ed. Medicală AMALTEA, București, 1997, 450-469.

BURGER JW, DE GRAAF EJ, DOORNEBOSCH P, GRÜNHAGEN D, BIERMANN K, DE WILT J, VERHOEF C – Local excision of rectal cancer after chemoradiation: feasibility depends on the primary stage. Int J Colorectal Dis, 2010, 25:1141–1142.

CARRIAGA MT, HENSON DE – The histologic grading of cancer. Cancer, 1995, 75(1): 406-421. Rectum, 2002, 45:1035-1040.

CATALANO V, LOUPAKIS F, GRAZIANO F, TORRESI U, BISONNI R, MARI D, FORNARO L, BALDELLI AM, GIORDANI P, ROSSI D, ALESSANDRONI P, GIUSTINI L, SILVA LL, FALCONE A, D’EMIDIO S, FEDELI SL – Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy. Br J Cancer, 2009, 100:881 – 887.

CHARBONNET P, GERVAZ P, ANDRES A, BUCHER P, KONRAD B, MOREL P – Results of emergency Hartmann's operation for obstructive or perforated left-sided colorectal cancer. World J Surg Oncol, 2008, 6:90 doi:10.1186/1477-7819-6-90.

CHEN HS, SHEEN-CHEN SM – Obstruction and perforation in colorectal adenocarcinoma: an analysis of prognosis and current trends. Surgery, 2000, 127(4):370-376.

CHEN HS, SHEEN-CHEN SM – Synchronous and „early” metachronous colorectal adenocarcinoma. Analysis of prognosis and current trends. Dis Colon Rectum, 2000, 43:1093-1099.

CHIANG JM, CHOU YW, CHEN TC, NG KF, LIN JL – Nuclear b-catenin expression is closely related to ulcerative growth of colorectal carcinoma. Br J Cancer, 2002, 86:1124 – 1129.

CHOI HK, LAW WL, POON J –The optimal number of lymph nodes examined in stage II colorectal cancer and its impact of on outcomes. BMC Cancer, 2010, 10:267.

CHUA W, GOLDSTEIN D, LEE CK, DHILLON H, MICHAEL M, MITCHELL P, CLARKE SJ, IACOPETTA B – Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer. Br J Cancer, 2009, 101:998–1004.

CHUN HK, CHOI D, KIM MJ, LEE J, YUN SH, KIM SH, LEE SJ, KIM CK – Preoperative staging of rectal cancer: comparison of 3-T high-field MRI and endorectal sonography. AJR, 2006, 187, 1557-1562.

CLARK ML, TALBOT IC, WILLIAMS CB – Tumors of the gastrointestinal tract. In: „Oxford Textbook of Medicine on CD-ROM“. Oxford University Press and AND Electronic Publishing B.V., 1996.

COHEN L, KASTENBERG D, MOUNT D, SAFDI A – Current issues in optimal bowel preparation. Gastroenterology & Hepatology, 2009, 5(11): S19.

COMPTON C, FENOGLIO-PREISER C, PETTIGREW N, FIELDING P – American Joint Committee on Cancer prognostic factors consensus conference. Cancer, 2000, 88:1739-1757.

COMPTON CAROLYN – Colorectal carcinoma: diagnostic, prognostic, and molecular features. Mod Pathol, 2003, 16(4):376–388.

COMPTON CAROLYN – Key issues in reporting common cancer specimens: problems in pathologic staging of colon cancer. Arch Pathol Lab Med, 2006, 130:318–324.

CONSTANTINOIU S, MOCANU AR, PREDESCU D, PREDESCU V – Intervenții seriate în chirurgia cancerului de colon stâng ocluziv – evoluție imediată. Chirurgia, 1999, 94(6):459-467.

CONTU P, CONTU S, MOREIRA L – Bcl-2 expression in rectal cancer. Arq Gastroenterol, 2006, 43(4):284-287.

COPOTOIU C – Tumorile benigne și maligne ale colonului. În: “Tratat de patologie chirurgicală” (sub red. Angelescu N.). Editura Medicală, București, 2001, vol. II, 1656-1689.

COTRAN R, KUMAR V, COLLINS T (eds) – Robbins Pathologic Basis of Disease. W.B. Saunders Company, Sixth Edition, (Philadelphia, London, Toronto, Montreal, Sidney, Tokyo), 1999.

COTRUZ EC, COTRUZ C – Celulele entero-endocrine: trecut, prezent și viitor. Editura APOLLONIA, Iași, 1998.

CRAWFORD J – The Gastrointestinal Tract. In: “Robbins Pathologic Basis of Disease” 6th Edition (Cotran R, Kumar V, Collins T eds). W.B. Saunders Company, Philadelphia, 1999.

CUCINO C, BUCHNER AM, SONNENBERG A – Continued rightward shift of colorectal cancer. Dis Colon Rectum, 2002, 45:1035-1040.

CURLESS R, FRENCH J, WILLIAMS GV, JAMES OFW – Comparison of gastrointestinal symptoms in colorectal carcinoma patients and community controls with respect to age. Gut, 1994, 35:1267-1270.

Den DULK M, MARIJNEN C, PUTTER H, RUTTEN H, BEETS G, WIGGERS T, NAGTEGAAL I, van de VELDE C – Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial. Ann Surg, 2007, 246:83–90.

DESCHOOLMEESTER V, BAAY M, Van MARCK E, WEYLER J, VERMEULEN P, LARDON F, VERMORKEN J – Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients. BMC Immunology, 2010, 11:19.

De WILT J, VERMAAS M, FERENSCHILD F, VERHOEF C – Management of locally advanced primary and recurrent rectal cancer. Clin Colon Rectal Surg, 2007, 20:255–264.

DIACONU C, DOGARU C, SCRIPCARIU V, STOIAN M, DRAGOMIR C – Cancerele sincrone ale colonului. Chirurgia, 2002, 97(4):351-355.

DICULESCU M, IACOB R, IACOB S, CROITORU A, BECHEANU G, POPENECIU V – The importance of histopathological and clinical variables in predicting the evolution of colon cancer. Rom J Gastroenterol, 2002, 11(3):183-190.

DOI T, BOKU N, KATO K, KOMATSU Y, YAMAGUCHI K, MURO K, HAMAMOTO Y, SATO A, KOIZUMI W, MIZUNUMA N, TAKIUCHI H – Phase I/II study of Capecitabine plus Oxaliplatin (XELOX) plus Bevacizumab as first-line therapy in Japanese patients with metastatic colorectal cancer. Jpn J Clin Oncol, 2010, 40(10):913–920.

DORAN H, PĂTRAȘCU T, CATRINA E, MIHALACHE O – Operația Hartmann. Evaluarea unei experiențe clinice de 30 de ani. Chirurgia, 2008, 103(4):413-416.

DUȚU RODICA – Diagnosticul morfologic al carcinoamelor. Editura Medicală, București, 1985, 339-373.

El DEMELLAWY D, KHALIFA MA, ISMIIL N, WONG S, GHORAB Z – Primary colorectal small cell carcinoma: a clinicopathological and immunohistochemical study of 10 cases. Diagnostic Pathology, 2007, 2:35.

ERKEK B, OZKAN N, BAYAR S, GENC V, UNAL E, KUZU A, ARIBAL D – Subsite distribution of colorectal carcinoma and implications for screening; a retrospective audit of 1771 cases. Hepato-Gastroenterology, 2007, 54:77-80.

ERLICHMAN C, SARGENT D – New treatment options for colorectal cancer. NEJM, 2004, 351(4):391-392.

FALLAHZADEH H – Leiomyosarcoma of colon: report of two cases. Am Surg, 1995, 61(4):294-296.

FENG-YING LI, MAO-DE LAI – Colorectal cancer, one entity or three? J Zhejiang Univ Sci B, 2009, 10(3):219-229.

FERENSCHILD F, DAWSON I, DE WILT J, DE GRAAF E, GROENENDIJK R, TETTEROO G – Total mesorectal excision for rectal cancer in an unselected population: quality assessment in a low volume center. Int J Colorectal Dis, 2009, 24:923–929.

FERLAY J, AUTIER P, BONIOL M, HEANUE M, COLOMBET M, BOYLE P – Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol, 2007, 18:581–592.

FERNÁNDEZ SP, DÍAZ SP, CALVIÑO BP, SANTAMARÍA PG, PILLADO TS, MONREAL FA – Diagnosis delay and follow-up strategies in colorectal cancer. Prognosis implications: a study protocol. BMC Cancer, 2010, 10:528.

FILIZ AI, SUCULLU I, KURT Y, KARAKAS DO, GULEC B, AKIN ML – Persistent high postoperative carcinoembryonic antigen in colorectal cancer patients – is it important? Clinics, 2009, 64(4):287-294.

FINAN P, CAMPBELL S, VERMA R, MACFIE J, GATT M, PARKER M, BHARDWAJ R, HALL N – The management of malignant large bowel obstruction: ACPGBI position statement. Colorectal Disease, 2007, 9(S4):1-17.

FOLKESSON J, BIRGISSON H, PAHLMAN L, CEDEMARK B, GLIMELIUS B, GUNNARSSON U – Swedish rectal cancer trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol, 2005, 23(24):5644-5649.

FRANCOUAL M, ETIENNE-GRIMALDI MC, FORMENTO JL, BENCHIMOL D, BOURGEON A, CHAZAL M, LETOUBLON C, ANDRE T, GILLY N, DELPERO JR, LASSER P, SPANO JP, MILANO G – EGFR in colorectal cancer: more than a simple receptor. Ann Oncol, 2006, 17:962–967.

FRIZELLE FA, HOBDAY K, BATTS KP, NELSON H – Adenosquamous and squamous carcinoma of the colon and upper rectum: a clinical and histopathology study. Dis Colon Rectum, 2000, 44(3):341-346.

FUJITA T, MATSUI M, TAKAKU K – Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas. Cancer Res, 1998, 58:4823-4826.

FUNARIU G, MIHUȚ IV, POP CE, GOMBOȘOIU C, GRECEA D, SCURTU R, DINDELEGAN G – Conduita chirurgicală în ocluziile rectocolice neoplazice. Chirurgia, 2003, 98(1):43-48.

GHEORGHE LS, GHEORGHE C, CAZACU M – Cancerul colorectal. În: “Tratat de Gastroenterologie”, vol. 2, (sub red. Grigorescu M). Ed. Medicală Națională, București, 2001, 139-173.

GILLILAND R, WILLIAMSON K, WILSON R, ANDERSON N, HAMILTON P – Colorectal cell kinetics. Br J Surg, 1996, 83:739-749.

GOH HS, YAO J, SMITH D – p53 Point Mutation and Survival in Colorectal Cancer Patients. Cancer Research, 1995, 55:5217-5221.

GOH KL, QUEK KF, YEO GT, HILMI I, LEE C, HASNIDA N, AZNAN M, KWAN KL, ONG KT – Colorectal cancer in Asians: a demographic and anatomic survey in Malaysian patients undergoing colonoscopy. Aliment Pharmacol Ther, 2005, 22: 859–864.

GOLDMAN S, GLIMELIUS B, PAHLMAN L – Anorectal malignant melanoma in Sweden: report of 49 patients. Dis Colon Rectum, 1990, 33(10):874-877.

GOMEZ D, DALAL Z, RAW E, ROBERTS C, LYNDON PJ – Anatomical distribution of colorectal cancer over a 10 year period in a district general hospital: is there a true „rightward shift”? – Postgrad Med J, 2004, 80:667-669.

GRANDE M, MILITO G, ATTINÀ GM, CADEDDU F, MUZI MG, NIGRO C, RULLI F, FARINON AM – Evaluation of clinical, laboratory and morphologic prognostic factors in colon cancer. World J Surg Oncol, 2008, 6:98 doi:10.1186/1477-7819-6-98

GREENE F, STEWART A, NORTON H – A new TNM staging strategy for node-positive (stage III) colon cancer. An analysis of 50.042 patients. Ann Surg, 2002, 236(4):416-421.

GREENE F, PAGE D, FLEMING I – AJCC cancer staging handbook, 6th edition. Springer Verlag, 2002, 12-1:12-3.

GREEN J, TIMMCKE A, MITCHELL W, HITCKS T, GATHRIGHT J Jr, RAY J – Mucinous carcinoma – just another colon cancer? Dis Colon Rectum, 1993, 36(1):49-54.

HAMILTON W, SHARP D – Diagnosis of colorectal cancer in primary care: the evidence base for guidelines. Familly Practice, 2004, 21(1):99-106.

HARRIS DA, EGBEARE D, JONES S, BENJAMIN H, WOODWARD A, FOSTER ME – Complications and mortality following stoma formation. Ann R Coll Surg Engl, 2005, 87:427–431.

HASEBE T, MORIHIRO M, SASAKI S, SHIMODA T, SUGITOH M, MORIYA Y, ONO M, ARAI T, OCHIAI A – Tumor thickness is a histopathologic predictive parameter of tumor metastasis and prognosis in patients with Dukes C ulcerative-type colorectal carcinoma: a two hospital based-study. Cancer, 2000, 89:35-45.

HEALD R, MORAN B, RYALL R, SEXTON R, MacFARLANE J – Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg, 1998, 133:894-899.

HEITMAN SJ, HILSDEN RJ, AU F, DOWDEN S, MANNS BJ – Colorectal cancer screening for average-risk North Americans: an economic evaluation. PLoS Med, 2010, 7(11):e1000370.

HEMMINKI K, SANTI I, WEIRES M, THOMSEN H, SUNDQUIST J, BERMEJO JL – Tumor location and patient characteristics of colon and rectal adenocarcinomas in relation to survival and TNM classes. BMC Cancer, 2010, 10:688.

HERIOT A, TEKKIS P, FAZIO V, NEARY P, LAVERY I – Adjuvant radiotherapy is associated with increased sexual dysfunction in male patients undergoing resection for rectal cancer: a predictive model. Ann Surg, 2005, 242:502–511.

HERMOSO FG, PALMA JP, GOMEZ JM, ROCHA NL, ARANA VM – Can early diagnosis of symptomatic colorectal cancer improve the prognosis? World J Surg, 2004, 28(7):716-720.

HERSZÉNYI L, FARINATI F, CARDIN R, ISTVÁN G, MOLNÁR L, HRITZ I, DE PAOLI M, PLEBANI M, TULASSAY Z – Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer. BMC Cancer, 2008, 8:194 (doi:10.1186/1471-2407-8-194).

HIDA J, YASUTOMI M, MARUYAMA T, NAKAJIMA A, UCHIDA T, WAKANO T, TOKORO T, FUJIMOTO K – Results from pelvic exenteration for locally advanced colorectal cancer with lymph node metastases. Dis Colon Rectum, 1998, 41:165-168.

IACOBUZIO-DONAHUE C – Epithelial neoplasms of the colorectum. In: „Gastrointestinal and Liver Pathology” (Iacobuzio-Donahue C, Montgomery E, eds). Churchill-Livingstone Elsevier, Philadelphia, 2005, 367-394.

IACOPETTA B –TP53 mutation in colorectal cancer. Human Mutation, 2003, 21:271-276.

IBBA-MANNESCHI L, MARTINI M, ZECCHI-ORLANDINI S, FAUSSONE-PELLEGRINI MS – Structural organization of enteric nervous system in man colon. Histol Histopathol, 1995, 10(1):17-25.

IKE H, SHIMADA H, OHKI S, TOGO S, YAMAGUCHI S, ICHIKAWA Y – Results of aggressive resection of lung metastases from colorectal carcinoma detected by intensive follow-up. Dis Colon Rectum, 2002, 45:468–475.

IONESCU G, SZABO IUDITH – Cancerul colic. În: „Chirurgia colonului“ (sub red Ionescu G). Editura Dacia, Cluj-Napoca, 1984, 330-335.

ISHIDA H, OHSAWA T, NAKADA H, HASHIMOTO D, OHKUBO T, ADACHI A, ITOYAMA S – Carcinosarcoma of the rectosigmoid colon: report of a case. Surg Today, 2003, 33:545-549.

JAKOB C, LIERSCH T, MEYER W, BECKER H, BARETTON G, AUST D – Predictive value of Ki67 and p53 in locally advanced rectal cancer: correlation with thymidylate synthase and histopathological tumor regression after neoadjuvant 5-FU-based chemoradiotherapy. World J Gastroenterol, 2008, 14(7): 1060-1066.

JHAWER M, GOEL S, WILSON A, MONTAGNA C, LING YH, BYUN DS, NASSER S, ARANGO D, SHIN J, KLAMPFER L, AUGENLICHT L, SOLER RP, MARIADASON J – PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor Cetuximab. Cancer Res, 2008, 68(6):1953-1961.

JEMAL A, SIEGEL R, WARD E, HAO Y, XU J, MURRAY T, THUN MJ – Cancer Statistics, 2008 – CA Cancer J Clin, 2007, 58(2): 71-96.

JEONG WK, PARK JW, LIM SB, CHOI HS, JEONG SY – Cefotetan versus conventional triple antibiotic prophylaxis in elective colorectal cancer surgery. J Korean Med Sci, 2010, 25:429-434.

JIANG M, MILNER J – Bcl-2 constitutively suppresses p53-dependent apoptosis in colorectal cancer cells. Genes Dev, 2003, 17:832-837.

JU JH, CHANG SC, WANG HS, YANG SH, JIANG JK, CHEN WC, LIN TC, HSU H, WANG FM, LIN JK – Changes in disease pattern and treatment outcome of colorectal cancer: a review of 5,474 cases in 20 years. Int J Colorectal Dis, 2007, 22:855-862.

KANAVOS P, SCHURER W, APENTEN CO, SULLIVAN R – Colorectal cancer in Europe and Australia: challenges and opportunities for the future. LSE Health, June 2008.

KANEKO K, KURAHASHI T, MAKINO R, KONISHI K, ITO H, KATAGIRI A, KUMEKAWA Y, HIRAYAMA Y, YONEYAMA K, KUSHIMA M, KUSANO M, TAJIRI H, REMBACKEN BJ, MITAMURA K, IMAWARI M – Pathological features and genetic alterations in colorectal carcinomas with characteristics of nonpolypoid growth. Br J Cancer, 2004, 91:312 – 318.

KANG H, O’CONNELL J, MAGGARD M, SACK J, KO C – A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum. Dis Colon Rectum, 2005, 48:1161–1168.

KERKEZ M, ĆULAFIĆ D, MIJAČ D, RANKOVIĆ V, LEKIĆ N, STEFANOVIĆ D – A study of pulmonary embolism after abdominal surgery in patients undergoing prophylaxis. World J Gastroenterol, 2009, 15(3):344-348.

KETTLEWELL MGW – Colorectal cancer and benign tumors of the colon. In „Oxford Textbook of Surgery on CD-ROM“. Oxford University Press and AND Electronic Publishing B.V., 1995.

KIANMANESH R, SCARINGI S, SABATE JM, CASTEL B, PONS-KERJEAN N, COFFIN B, HAY JM, FLAMANT Y, MSIKA S – Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases. Ann Surg, 2007, 245:597–603.

KIM SA, LEE JH, PARK SY, KIM H, KIM TI, KIM WH – Depressed-type of early colon cancer with extensive nodal metastasis. Yonsei Med J, 2007, 48(1):135-138.

KIM JY, KIM NK, SOHN SK, KIM YW, KIM JS, HUR H, MIN BS, CHO CH – Prognostic value of postoperative CEA clearance in rectal cancer patients with high preoperative CEA levels. Ann Surg Oncol, 2009, 16:2771–2778.

KIM HJ, LEE IK, LEE YS, KANG WK, PARK JK, OH ST, KIM JG, KIM YH – A comparative study on the short-term clinicopathologic outcomes of laparoscopic surgery versus conventional open surgery for transverse colon cancer. Surg Endosc, 2009, 23:1812–1817.

KIM CW, SHIN US, YU CS, KIM JC – Clinicopathologic characteristics, surgical treatment and outcomes for splenic flexure colon cancer. Cancer Res Treat, 2010, 42(2):69-76.

KIRCHHOFF P, CLAVIEN PA, HAHNLOSER D – Complications in colorectal surgery: risk factors and preventive strategies. Patient Safety in Surgery, 2010, 4:5.

KODNER I, FRY R, FLESHMAN J, BIRNBAUM E, READ T – Colon rect și anus. În: “Schwartz Principiile Chirurgiei” (Shires, Spencer, Daly, Fischer, Galloway eds), ed. A VII (rom.). Editura TEORA, București, 2005, 1266-1380.

KONISHI T, WATANABE T, KISHIMOTO J, KOTAKE K, MUTO T, NAGAWA H – Prognosis and risk factors of metastasis in colorectal carcinoids: results of a nationwide registry over 15 years. Gut, 2007, 56:863–868.

KRIWANEK S, ARMBRUSTER C, DITTRICH K, BECKERHINN P – Perforated Colorectal Cancer. Dis Colon Rectum, 1996, 39:1409-1414.

KUMAR G, RUDBECK L (eds) – Immunohistochemical (IHC) staining methods, 5th edition. Ed Dako North America, Carpinteria, California, 2009.

KÜNZLI B, FRIESS H, SHRIKHANDE S – Is laparoscopic colorectal cancer surgery equal to open surgery? An evidence based perspective. World J Gastrointest Surg, 2010, 2(4):101-108.

LANDMANN R, WEISER M – Surgical management of locally advanced and locally recurrent colon cancer. Clin Colon Rectal Surg, 2005, 18(3):182-189.

LAW WL, LEE YM, CHOI HK, SETO CL, HO J – Impact of laparoscopic resection for colorectal cancer on operative outcomes and survival. Ann Surg, 2007, 245:1–7.

LAW WL, CHU KW – Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients. Ann Surg, 2004, 240:260–268.

LAZĂR L, BĂDULESCU F, CEBOTARU C, CIULEANU T, RANCEA A – Carcinoamele colorectale: ghid de diagnostic și tratament. În: „Ghiduri de practică medicală”, vol. I, (sub red. Gherasim L). Ed. INFO MEDICA, București, 2000, 421-435.

LEVINE DS, HAGGITT RC – Colon. In „Histology for Pathologist“, second edition (eds. Sternberg S.S.). Lippincott-Raven Publishers, Philadelphia, 1997, 519-536.

LÊ P, MEHTARI L, BILLEY C – Les tumor de colon transverse. J Chir, 2006, 143(5):285-293.

LI M, GU J – Changing patterns of colorectal cancer in China over a period of 20 years. World J Gastroenterol, 2005, 11(30):4685-4688.

LIN OST – Computed tomographic colonography: hope or hype? World J Gastroenterol, 2010, 16(8): 915-920.

LIU Y, BODMER W – Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines. PNAS, 2006, 103(4):976-981.

LONGO W, VIRGO K, JOHNSON F, OPRIAN C, VERNAVA A, WADE T, PHELAN M, HENDERSON W, DALEY J, KHURI S – Risk factors for morbidity and mortality after colectomy for colon cancer. Dis Colon Rectum, 2000, 43:83-91.

LUBOLDT W, VOLKER T, WIEDEMANN B, ZÖPHEL K, WEHRMANN U, KOCH A, TOUSSAINT T, ABOLMAALI N, MIDDENDORP M, AUST D, KOTZERKE J, GRÜNWALD F, VOGL T, LUBOLDT HJ – Detection of relevant colonic neoplasms with PET/CT: promising accuracy with minimal CT dose and a standardized PET cut-off. Eur Radiol, 2010, 20:2274–2285.

MANDAVA N, KUMAR S, PIZZI W, APRILE J – Perforated colorectal carcinomas. Am J Surg, 1996, 172:236-238.

MANFREDI S, LEPAGE C, HATEM C, COATMEUR O, FAIVRE J, BOUVIER AM – Epidemiology and management of liver metastases from colorectal cancer. Ann Surg, 2006 244:254–259.

MARETT L, DRYER D, ELLISON L, LOGAN H, MERY L, MORRISON H, SCHACTER B – Canadian Cancer Statistics, 2008. Canadian Cancer Society/National Cancer Institute of Canada, 2008, www.cancer.ca

MARTIN TA, JIANG WG – Tight junctions and their role in cancer metastasis. Histol Histopathol, 2001, 16:1183-1195.

MATSUDA T, SAITO Y, FUJII T, URAOKA T, NAKAJIMA T, KOBAYASHI N, EMURA F, ONO A, SHIMODA T, IKEMATSU H, FU K, SANO Y, FUJIMORI T – Size does not determine the grade of malignancy of early invasive colorectal cancer. World J Gastroenterol, 2009, 15(22): 2708-2713.

MAYER RJ – Gastrointestinal tract cancer. In „Harrisson’s Principles of Internal Medicine, 14th Edition, on CD-ROM“. McGraw-Hill, 1998.

McPHEE SJ, PAPADAKIS M, TIERNEY L – Current medical diagnosis & treatment. McGraw&Hill, 2008.

McQUAID KR – Cancerul colorectal. În: „Diagnostic și tratament în practica medicală“, (Tierney LM, McPhee SJ, Papadakis MA eds.). McGraw Hill, 2001, 523-526.

MEHTA K, GOLDFARB M, ZINTERHOFER L – Absent p53 protein in colorectal tumor cells reflects poor survival. J Applied Research, 2002, 2(3).

METERISSIAN S, KONTOGIANNEA M, AL-SOWAIDI M, LINJAWI A, HALWANI F, JAMISON B, EDWARDES M – Bcl-2 is a useful prognostic marker in Dukes’ B colon cancer. Ann Surg Oncol, 2001, 8(6):533-637.

MING SC, GOLDMAN H (eds) – Pathology of the Gastrointestinal Tract, 2nd edition. Ed. Williams & Wilkins, Baltimore-Philadelphia-London-Paris, 1998.

MORRIS M, PLATELL C, FRITSCHI L, IACOPETTA B – Failure to complete adjuvant chemotherapy is associated with adverse survival in stage III colon cancer patients. Br J Cancer, 2007, 96:701 – 707.

MORRIS A, BALDWIN LM, MATTHEWS B, DOMINITZ J, BARLOW W, DOBIE S, BILLINGSLEY K – Reoperation as a quality indicator in colorectal surgery: a population-based analysis. Ann Surg, 2007, 245:73–79.

MORIYA Y, AKASU T, FUJITA S, YAMAMOTO S – Aggressive surgical treatment for patients with T4 rectal cancer. Colorectal Disease, 2003, 5:427-431.

MUNTEANU A, TUDOSE N, TABAN S – Evaluarea unor factori clinici și morfopatologici de prognostic în cancerul colo-rectal: studiu preliminar. Cercetări experimentale și medico-chirurgicale, 2004, 3:111-117

NABI U, NAGI A, SAMI W – Ki-67 proliferating index and histological grade, type and stage of colorectal carcinoma. J Ayub Med Coll Abbottabad, 2008, 20(4):44-48.

NAGTEGAAL I, Van de VELDE C, MARIJNEN C, Van KRIEKEN J, QUIRKE P – Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol, 2005, 23:9257-9264.

NAKAFUSA Y, TANAKA T, TANAKA M, KITAJIMA Y, SATO S, MIYAZAKI K – Comparison of multivisceral resection and standard operation for locally advanced colorectal cancer: analysis of prognostic factors for short-term and long-term outcome. Dis Colon Rectum, 2004, 47:2055–2063.

NAKAMURA T, MITOMI H, IHARA A, ONOZATO W, SATO T, OZAWA H, HATADE K, WATANABE M – Risk factors for wound infection after surgery for colorectal cancer. World J Surg, 2008, 32:1138-1141.

NEAGOE A, MOLNAR AM, ACALOVSCHI M, SEICEAN A, ȘERBAN A – Risk factors for colorectal cancer: an epidemiologic descriptive study of a series of 333 patients. Rom J Gastroenterol, 2004, 13(3):187-193.

NEWLAND R, DENT O, CHAPUIS P, BOKEY L – Survival after curative resection of lymph node negative colorectal carcinoma: a prospective study of 910 patients. Cancer, 1995, 76:564-571.

Ni SJ, Sheng WQ, Du X – Pathologic research update of colorectal neuroendocrine tumors. World J Gastroenterol, 2010, 16(14): 1713-1719.

NISSAN A, GUILLEM J, PATY P, WONG D, COHEN A – Signet-ring cell carcinoma of the colon and rectum: a matched control study. Dis Colon Rectum, 1999, 42:1176-1180.

NOJIMA H, SEIKE K, KOSUGI C, SHIDA T, KODA K, ODA K, KAMATA S – Advanced moderately differentiated neuroendocrine carcinoma of the rectum with favorable prognosis by postoperative chemoradiation. World J Surg Oncol, 2010, 8:29.

NORTHROP J, LEE J – Large bowel carcinoid tumors. Curr Opin Gastroenterol, 2007, 23(1):74-78.

O’CONNEL J, MAGGARD M, KO C – Colon cancer survival rates with the new American Joint Comitee on Cancer Sixth edition staging. J Natl Cancer Instit, 2004, 96:1420-1425.

OGATA Y, MATONO K, HAYASHI A, TAKAMOR S, MIWA K, SASATOMI T, ISHIBASHI N, SHIDA S, SHIROUZU K – Repeat pulmonary resection for isolated recurrent lung metastases yields results comparable to those after first pulmonary resection in colorectal cancer. World J Surg, 2005, 29:363–368.

OGINO S, BRAHMANDAM M, CANTOR M, NAMGYAL C, KAWASAKI T, KIRKNER G, MEYERHARDT J, LODA M, FUCHS C – Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component. Modern Pathology, 2006, 19:59–68.

OGINO S, NOSHO K, IRAHARA N, SHIMA K, BABA Y, KIRKNER G, KENUDSON M, GIOVANNUCCI E, MEYERHARDT J, FUCHS C – Negative lymph node count is associated with survival of colorectal cancer patients, independent of tumoral molecular alterations and lymphocytic reaction. Am J Gastroenterol, 2010, 105(2):420–433.

OKUBO H, OZEKI K, TANAKA T, MATSUO T, MOCHINAGA N – Primary malignant fibrous histiocytoma of the ascending colon: report of a case. Surg Today, 2005, 35:323-327.

ORTHOLAN C, FRANCOIS E, THOMAS O, BENCHIMOL D, BAULIEUX J, BOSSET J, GERARD J – Role of radiotherapy with surgery for T3 and resectable T4 rectal cancer: evidence from randomized trials. Dis Colon Rectum, 2006, 49:302–310.

PAGÈS F, BERGER A, CAMUS M, SANCHEZ-CABO F, COSTES A, MOLIDOR R, MLECNIK B, KIRILOVSKY A, NILSSON M, DAMOTTE D, MEATCHI T, BRUNEVAL P, CUGNENC PH, TRAJANOSKI Z, FRIDMAN WH, GALON J – Effector memory T cells, early metastasis, and survival in colorectal cancer. NEJM, 2005, 353(25):2654-2666.

PAMBUCCIAN G – Tumorile intestinului. În „Anatomie patologică“, vol. II (sub red Moraru I.). Ed. Medicală, București, 1980, 280-284.

PANDE R, SUNGA A, LEVEA C, WILDING G, BSHARA W, REID M, FAKIH M – Significance of signet-ring cells in patients with colorectal cancer. Dis Colon Rectum, 2008, 51:50–55.

PEDRAZZANI C, CERULLO G, DE MARCO G, MARRELLI D, NERI A, DE STEFANO A, PINTO E, ROVIELLO F – Impact of age-related comorbidity on results of colorectal cancer surgery. World J Gastroenterol, 2009, 15(45):5706-5711.

PERRY B, CONNAUGHTON C – Abdominoperineal resection: how is it done and what are the results? Clinics in Colon and Rectal Surgery, 2007, 20(3):213-220

POPOVICI A (red.) – Chirurgia colonului, rectului și canalului anal. Tehnici chirurgicale, vol. 1. Editura Medicală, București, 2003.

PRICOP C, PĂDUREANU S, DĂNILĂ R, BURCOVEANU C, DIACONU C, PLEȘA C – Cancerul de colon complicat cu ocluzie și perforație. Jurnalul de Chirurgie (Iași), 2010, 6(1):35-39.

PSATHAKIS D, SCHIEDECK T, KRUG F, OEVERMANN E, KUJATH P, BRUCH HP – Ordinary colorectal adenocarcinoma vs. primary colorectal signet-ring cell carcinoma: study matched for age, gender, grade, and stage. Dis Colon Rectum, 1999, 42:1618-1625.

PUIA C – Chirurgia laparoscopică a colonului și rectului. În: “Chirurgia laparoscopică”, (sub red. Duca S), ediția a II-a. Editura Paralela 45, 2001, 343-360.

QIU CZ, WANG C, HUANG ZX, ZHU SZ, WU YY, QIU JL – Relationship between somatostatin receptor subtype expression and clinicopathology, Ki-67, Bcl-2 and p53 in colorectal cancer. World J Gastroenterol, 2006, 12(13):2011-2015.

RAICA M – Histologia sistemului digestiv. Seria „Histologia pentru patolog”, Timișoara, 2000, 101-119.

RANGA V – Intestinul gros. În „Anatomia omului. Viscere – tubul digestiv abdominal și glandele anexe“. Ed. „CERMA“, București, 1994; 82-120.

RĂDULESCU D, BELUȘICĂ L (sub red.) – Caiete de chirurgie practică (ed. a II-a), vol. II. Ed. Medicală, București, 1999.

RICHARDS CH, LEITCH F, HORGAN P, McMILLAN D – A systematic review of POSSUM and its related models as predictors of post-operative mortality and morbidity in patients undergoing surgery for colorectal cancer. J Gastrointest Surg, 2010, 14:1511–1520.

ROBERTSON D, STUKEL T, GOTTLIEB D, SUTHERLAND J, FISHER E – Survival following hepatic resection of colorectal cancer metastases: a national experience. Cancer, 2009, 115(4):752–759.

RODRIGUES N, ROWAN A, SMITH M, KERR I, BODMER W, GANNON J, LANE D – p53 mutations in colorectal cancer. Proc Natl Acad Sci, 1990, 87:7555-7559.

ROSEN L, STASIK JJ, REED JF, OLENWINE JA, ARONOFF JS, SHERMAN D – Variations in colon and rectal surgical mortality. Dis Colon Rectum, 1996, 39(2):129-135.

SAIDI H, NYAIM E, GITHAIGA J, KARURI D – CRC surgery trends in Kenya, 1993–2005. World J Surg, 2008, 32:217–223.

SAJIN M. – Anatomie patologică macroscopică. Editura CERMA, București, 2000, 40-43.

SAWAI H, YASUDA A, OCHI N, MA J, MATSUO Y, WAKASUGI T, TAKAHASHI H, FUNAHASHI H, SATO M, TAKEYAMA H – Loss of PTEN expression is associated with colorectal cancer liver metastasis and poor patient survival. BMC Gastroenterology, 2008, 8:56.

SÂRBU-BOEȚI MP – Actualități despre fistulele digestive postoperatorii: etiopatogenie, diagnostic și tratament. Editura Celsius, București, 2006.

SCABINI S, RIMINI E, ROMAIRONE E, SCORDAMAGLIA R, DAMIANI G, PERTILE D, FERRANDO V – Colon and rectal surgery for cancer without mechanical bowel preparation: one-center randomized prospective trial. World J Surg Oncol, 2010, 8:35.

SCHLEMPER R, ITABASHI M, KATO Y, LEWIN K, RIDDELL R, SHIMODA T, SIPPONEN P, STOLTE M, WATANABE H – Differences in the diagnostic criteria used by Japanese and Western pathologists to diagnose colorectal carcinoma. Cancer, 1998, 82:60–69.

SCHULMANN K, REISER M, SCHMIEGEL W – Colonic cancer and polyps. Best Practice and Research Clinical Gastroenterology, 2002, 16(1):91-114.

SCRIPCARIU V, LUNGU M, DRAGOMIR R, LEFTER L, RADU I, DRAGOMIR C – Rezecția anterioară de rect pentru cancerul rectal – opțiuni, limite, complicații imediate. Chirurgia, 2004, 99(5):305-310.

SECCO G, RAVERA G, GASPARO A, PERCOCO P, ZOLI S – Segmental resection, lymph nodes dissection and survival in patients with left colon cancer. Hepato-Gastroenterology, 2007, 54:422-426.

SHEN S, HAUPT B, RO J, ZHU J, BAILEY R, SCHWARTZ M – Number of lymph nodes examined and associated clinicopathologic factors in colorectal carcinoma. Arch Pathol Lab Med, 2009, 133:781–786.

SHIN JY, HONG KH – Risk factors for early postoperative small-bowel obstruction after colectomy in colorectal cancer. World J Surg, 2008, 32:2287-2292.

SILBART L, KEREN D – Structure and function of the gastrointestinal immune system. In ”Pathology of the Gastrointestinal Tract”, 2nd edition (eds Si-Chunn Ming, Harvey Goldman). Williams&Wilkins, Baltimore-Philadelphia-London-Paris, 1998, 99-111.

SKIBBER J, MINSKY B, HOFF P – Cancer of the colon. In „Cancer: Principles and Practice of Oncology” vol. III, (DeVita V, Hellman S, Rosenberg S eds). Lippincot Williams & Wilkins Sixth Edition, 2001.

SOHN DK, CHANG HJ, PARK JW, CHOI DH, HAN KS, HONG CW, JUNG KH, KIM DY, LIM SB, CHOI HS, JEONG SY – Histopathological risk factors for lymph node metastasis in submucosal invasive colorectal carcinoma of pedunculated or semipedunculated type. J Clin Pathol, 2007, 60:912–915.

SPANO J, LAGORCE C, ATLAN D, MILANO G, DOMONT J, BENAMOUZIG R, ATTAR A, BENICHOU J, MARTIN A, MORERE J, RAPHAEL M, PENAULT-LLORCA F, BREAU J, FAGARD R, KHAYAT D, WIND P – Impact of EGFR expression on colorectal cancer patient prognosis and survival. Ann Oncol, 2005, 16:102–108.

STEINBERG S, BARWICK K, STABLEIN D – Importance of tumor pathology and morphology in patients with surgically resected colon cancer. Findings from the Gastrointestinal Tumor Study Group. Cancer, 1986, 58:1340-1345

STOCCHI L, NELSON H – Diagnostic and therapeutic applications of monoclonal antibodies in colorectal cancer. Dis Colon Rectum, 1998, 41:232-250.

STOIDIS C, SPYROPOULOS B, MISIAKOS E, FOUNTZILAS C, PARASKEVA P, FOTIADIS C – Diffuse anorectal melanoma; review of the current diagnostic and treatment aspects based on a case report. World J Surg Oncol, 2009, 7:64 doi:10.1186/1477-7819-7-64

SUGARBAKER P, Van der SPEETEN K, STUART A – Pharmacologic rationale for treatments of peritoneal surface malignancy from colorectal cancer. World J Gastrointest Oncol, 2010, 2(1):19-30.

SUGARBAKER P – Surgical management of carcinomatosis from colorectal cancer. Clin Colon Rectal Surg, 2005, 18(3):190-203.

SUN LC, CHU KS, CHENG SC, LU CY, KUO CH, HSIEH JS, SHIH YL, CHANG SJ, JY WANG – Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment. BMC Cancer, 2009, 9:288 doi: 10.1186/1471-2407-9-288.

TAKADA H, OHSAWA T, IWAMOTO S, YOSHIDA R, NAKANO M, IMADA S, YOSHIOKA K, OKUNO M, MASUYA Y, HASEGAWA K, KAMANO N, HIOKI K, MUTO T, KOYAMA Y – Changing site distribution of colorectal cancer in Japan. Dis Colon Rectum, 2002, 45:1249–1254.

TAUPENOT L, HARPER K, O’CONNOR D – The chromogranin–secretogranin family. N Engl J Med, 2003, 348:1134-1149.

THORNE A, MERCER S, HARRIS G, SIMSON J – Reduction in late diagnosis of colorectal cancer following introduction of a specialist colorectal surgery service. Ann R Coll Surg Engl, 2006, 88:562–565.

TROMPETAS V – Emergency management of malignant acute left-sided colonic obstruction. Ann R Coll Surg Engl, 2008, 90:181–186.

TSAI HL, CHENG K, LU CY, KUO CH, MA CJ, WU JY, CHAI CY, HSIEH JS, WANG JY – Prognostic significance of depth of invasion, vascular invasion and number of lymph node retrievals in combination for patients with stage II colorectal cancer undergoing radical resection. J Surg Oncol, 2008, 97:383-387.

TUDOSE N – Morfopatologie. Ed. MIRTON, Timișoara, 1996, vol. II, 84-87.

VALBUENA JR, GUALCO G, ESPEJO-PLASCENCIA I, MEDEIROS LJ – Classical hodgkin lymphoma arising in the rectum. Ann Diagnostic Pathol, 2005, 9:38-42.

Van der VOORT van ZIJP J, HOEKSTRA H, BASSON M – Evolving management of colorectal cancer. World J Gastroenterol, 2008, 14(25):3956-3967.

VĂLEAN S, ARMEAN P, RESTEMAN S, NAGY G, MUREȘAN A, MIRCEA P – Cancer mortality in Romania, 1955-2004. Digestive sites: esophagus, stomach, colon and rectum, pancreas, liver, gallbladder and biliary tree. J Gastrointestin Liver Dis, 2008, 17(1):9-14.

VIKRAM R, IYER R – PET/CT imaging in the diagnosis, staging, and follow-up of colorectal cancer. Cancer Imaging, 2008, 8:S46-S51.

VILLAR J, MARTINEZ A, VILLEGAS M, MUFFAK K, MANSILLA A, GARROTE D, FERRON J – Surgical options for malignant left-sided colonic obstruction. Surg Today, 2005, 32:275-281.

VIRONEN J, JUHOLA M, KAIRALUOMA M, JANTUNEN I, KELLOKUMPU I – Tumour regression grading in the evaluation of tumour response after different preoperative radiotherapy treatments for rectal carcinoma. Int J Colorectal Dis, 2005, 20(5):440-445.

VYSLOUŽIL K, CWIERTKA K, ZBOŘIL P, KUČEROVA L, KLEMENTA I, STARY L, SKALICKY P, DUDA M – Endorectal sonography in rectal cancer staging and indication for local surgery. Hepato-Gastroenterology, 2007, 54:1102-1106.

WAHLS T, PELEG I – Patient and system-related barriers for the earlier diagnosis of colorectal cancer. BMC Family Practice, 2009, 10:65 (doi:10.1186/1471-2296-10-65).

WAISBERG J, BROMBERG SH, FRANCO MI, MATHEUS CO, ZANOTTO A, PETROLINO LF, BELTRAMI AM, GODOY AC – Primary non-Hodgkin lymphoma of the right colon: a retrospective clinical-pathological study. Int Surg, 2001, 86(1):20-25.

WANG TK, CHUNG MT – Anorectal leiomyosarcomas. J Gastroenterol, 1998, 33(3):402-440.

WASHINGTON MK, BERLIN J, BRANTON P, BURGART L, CARTER D, FITZGIBBONS P, HALLING K, FRANKEL W, JESSUP J, KAKAR S, MINSKY B, NAKHLEH R, COMPTON C – Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum. Arch Pathol Lab Med, 2009, 133(10): 1539–1551.

WATSON AJ, LOLOHEA S, ROBERTSON G, FRIZELLE F – The role of positron emission tomography in the management of recurrent colorectal cancer: a review. Dis Colon Rectum, 2006, 50:102–114.

WATTACHERIL J, KRAMER JR, RICHARDSON P, HAVEMANN BD, GREEN LK, EL-SERAG HB – Lagtimes in diagnosis and treatment colorectal cancer: determinants and association with cancer stage and survival. Aliment Pharmacol Ther, 2008, 28(9):1166–1174.

WEBER JC, BACHELLIER P, JAEK D – Opțiuni terapeutice în metastazele hepatice ale cancerelor colorectale. În: “Chirurgia ficatului” vol. I (sub red. Popescu I). Editura Universitară “Carol Davila”, București, 2004, 413-427.

WEDEL T, ROBLICK U, GLEISS J, SCHIEDECK T, BRUCH HP, KUHNEL W, KRAMMER HJ – Organization of the enteric nervous system in the human colon demonstrated by wholemount immunohistochemistry with special reference to the submucous plexus. Ann Anat, 1999, 181(4):327-337.

WEYANDT GH, EGGERT AO, HOUF M, RAULF F, BRÖCKER EB, BECKER JC – Anorectal melanoma: surgical management guidelines according to tumour thickness. Br J Cancer, 2003, 89:2019 – 2022.

WILLIAMS P (ed.) – Gray’s Anatomy: the anatomical basis of medicine and surgery, 38th edition. Harcourt Brace and Company Limited, London, 1999.

WINTER D, WALSH R, LEE G, KIELY D, RIORDAIN MG, SULLIVAN GC – Local involvement of the urinary bladder in primary colorectal cancer: outcome with en-bloc resection. Ann Surg Oncol, 2007, 14(1):69–73.

YADA H, SAWAI K, TANIGUCHI H, HOSHIMA M, TAKAHASHI T – Analysis of vascular anatomy and lymph node metastases warrants radical segmental bowel resection for colon cancer. World J Surg, 1997, 21:109-115.

YAMAMOTO S, YOSHIMURA K, RI S, FUJITA S, AKASU T, MORIYA Y – The risk of multiple malignancies with colorectal carcinoma. Dis Colon Rectum, 2006, 49(10):S30-S36.

ZAUBER A, LANSDORP-VOGELAAR I, KNUDSEN A, WILSCHUT J, VAN BALLEGOOIJEN M, KUNTZ K – Evaluating test strategies for colorectal cancer screening a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med, 2008, 149(9):659–669.

ZHAO DB, WU YK, SHAO YF, WANG CF, CAI JQ – Prognostic factors for 5-year survival after local excision of rectal cancer. World J Gastroenterol, 2009, 15(10): 1242-1245.

ZLOBEC I, LUGLI A – Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors. World J Gastroenterol, 2009, 15(47):5898-5906.